Inventor

Rong Wang

Inventor
Bethesda, MD, US

Overview

24→
Patents
1998–2019
Patent span
Human necessities
Primary field (CPC A)

Patents· 24 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes19%
C07KPeptides19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
A01KAnimal husbandry9%
C12NMicroorganisms or enzymes9%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
C07HSugars4%
Y02ATechnologies for adaptation to climate change4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
Y10TTechnical subjects covered by former us classification4%
PatentTitleYear
10,251,912MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-120199,447,144'MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1'20168,754,046'MHC class II restricted T cell epitopes from the cancer anitgen, NY ESO-1'20148,318,697'Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds'20128,211,445'PSM peptides as vaccine targets against methicillin-resistant Staphylococcus'20128,066,995'Anti-myostatin antibodies'20117,902,159'Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds'20117,745,583'Anti-myostatin antibodies'20107,635,760'Anti-myostatin antibodies'20097,632,499'Anti-myostatin antibodies'20097,619,057'MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1'20097,341,874'Method for detecting post-translation modifications of peptides'20087,084,239'Cancer peptides of NY-ESO-1/CAG-3'20067,015,312'Antibodies to the protein product encoded by ORF3 of the TRP-1 gene and compositions and kits thereof'20067,001,600'Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes'20066,800,613'Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds'20046,750,061'Method and product for the sequence determination of peptides using a mass spectrometer'20046,271,037'Method and product for the sequence determination of peptides using a mass spectrometer'20016,132,980'Antibodies specific for TRP-2 a human tumor antigen recognized by cytotoxic T lymphocytes'20006,087,110'Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein'20006,083,703'Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes'20005,840,839'Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein'19985,831,016'Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes'19985,792,664'Methods for producing and analyzing biopolymer ladders'1998

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1998–2019Patents assigned to US HEALTH (12)· patent assignee history
1998–2008Patents assigned to SCRIPPS RESEARCH INST (4)· patent assignee history
1998–2008Patents assigned to UNIV ROCKEFELLER (4)· patent assignee history
1998–2006Based in Bethesda, MD, US· patent location history
1998–2008Based in New York, NY, US· patent location history
2004–2012Patents assigned to CORIXA CORP (3)· patent assignee history
2004–2012Based in Missoula, MT, US· patent location history
2009–2011Patents assigned to LILLY CO ELI (4)· patent assignee history
2009–2019Based in Houston, TX, US· patent location history
2010–2011Based in Wildwood, MO, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
US HEALTH121998–2019
LILLY CO ELI42009–2011
SCRIPPS RESEARCH INST41998–2008
UNIV ROCKEFELLER41998–2008
CORIXA CORP32004–2012
Locations
LocationPatentsSpan
Bethesda, Maryland, US81998–2006
Houston, Texas, US42009–2019
New York, New York, US41998–2008
Missoula, MT, US32004–2012
Wildwood, MO, US22010–2011